Fast Locator 2012-2013: Suzhou Pharma Services - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Fast Locator 2012-2013: Suzhou Pharma Services

Suzhou Pharma Outsourcing Services

Suzhou Pharma Services
9 Polito Ave., Suite 900
Lyndhurst, NJ 07071
tel. 732.993.9822

Sales Contact:

Marc Finn

Year Founded:


Regions where services are provided:

North America, Asia.

Number of Employees:


Annual Revenues:

$0–10 million

Outsourcing services provided:

Analytical Services

  • Chemistry & stability
  • Particle characterization
  • Product characterization

Commercial Manufacturing

  • Ingredient processing
  • Solid-dose manufacturing

Consulting Services

  • Project & sourcing management
  • Regulatory, Validation, IT, & QA/QC Services

Development and Phase I/II CTM

  • Solid-dose, semisolids, & liquids development

Packaging & Logistics

  • Clinical labels
  • Clinical packaging & distribution
  • Commercial packaging




blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here